Development of a prognostic index based on immunogenomic landscape analysis in glioma
Abstract Background Glioma is the most common intracranial tumor. The inflammatory response actively participates in the malignancy of gliomas. There is still limited knowledge about the biological function of immune‐related genes (IRGs) and their potential involvement in the malignancy of gliomas....
Main Authors: | Haitao Luo, Chuming Tao, Peng Wang, Jingying Li, Kai Huang, Xingen Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.407 |
Similar Items
-
Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma
by: Zesheng Peng, et al.
Published: (2023-04-01) -
MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
by: Chunyu Zhang, et al.
Published: (2022-08-01) -
Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
by: Zewei Tu, et al.
Published: (2021-02-01) -
Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
by: Shenghua Zhuo, et al.
Published: (2023-12-01) -
Expression and Prognostic Role of Glia Maturation Factor-γ in Gliomas
by: Junhui Liu, et al.
Published: (2022-06-01)